Absolutely, I often wonder the same.
It’s certainly not the price action that’s keeping people from posting as anyone can see it has a spectacular chart.
It’s successfully going into new territory to treat Cancer and Idiopathic Pulmonary Fibrosis and it’s been awarded two FDA approvals.
It’s peers are in the 400m $us market cap .... AMP945 is proving to be more successful than its competitors.
I see this as one hell of an opportunity ...
.
Ann: Amplia Initiates Multiple Dose Study of AMP945, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
